Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-099203
Filing Date
2025-07-28
Accepted
2025-07-28 16:30:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9434
2 EX-99.1 ck0000000000-ex99_1.pdf EX-99.1 78597
3 EX-99.2 ck0000000000-ex99_2.pdf EX-99.2 83514
  Complete submission text file 0000950170-25-099203.txt   234730
Mailing Address 301 COMMERCE STREET FORT WORTH TX 76102
Business Address 301 COMMERCE STREET FORT WORTH TX 76102 (817) 871-4000
TSSP Sub-Fund HoldCo LLC (Filed by) CIK: 0001677508 (see all company filings)

EIN.: 471544003
Type: SCHEDULE 13G

Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Subject) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-95084 | Film No.: 251155991
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)